当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析 - 资产负债表

睿智医药

(300149)

  

流通市值:24.70亿  总市值:24.74亿
流通股本:4.99亿   总股本:5.00亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金331,046,367.03347,259,606.5294,169,260.64263,293,292.89
应收票据及应收账款234,103,763.64263,852,545.51296,500,306.07326,000,896.15
应收账款234,103,763.64263,852,545.51296,500,306.07326,000,896.15
预付款项6,887,138.9210,342,934.8212,687,240.4821,761,186.43
其他应收款合计17,362,357.4512,010,653.4187,216,163.5890,047,823.26
存货20,833,132.1227,882,102.2160,529,369.837,495,645.48
合同资产7,365,099.024,254,346.1616,500,735.1216,902,179.95
一年内到期的非流动资产347,533.36347,533.36--
其他流动资产56,988,039.7659,023,714.4739,775,832.4534,411,934.15
流动资产平衡项目0000
流动资产合计676,526,244.27727,179,070.94813,578,908.14805,512,958.31
非流动资产:
长期股权投资199,329,451.61197,494,208.01231,760,325.61230,713,641.91
其他非流动金融资产2,296,5002,296,5001,931,550.742,047,283.41
投资性房地产78,103,251.9479,212,318.1227,448,026.5722,280,910.56
固定资产366,646,718.61373,935,752.78499,101,457489,476,156.68
在建工程7,518,946.927,962,682.9848,095,287.8154,677,903.46
使用权资产450,162,025.55469,490,716.35483,157,476.93503,133,514.04
无形资产31,155,582.7630,047,608.0349,361,800.5354,384,539.26
商誉164,030,380.19164,030,380.19858,860,380.19858,860,380.19
长期待摊费用313,922,147.45324,355,752.21353,890,675.81355,212,595.82
递延所得税资产40,061,278.640,446,0339,748,628.0910,914,523.9
其他非流动资产41,431,635.2442,641,907.5134,189,746.3143,551,549.41
非流动资产平衡项目0000
非流动资产合计1,694,657,918.871,731,913,859.182,597,545,355.592,625,252,998.64
资产平衡项目0000
资产总计2,371,184,163.142,459,092,930.123,411,124,263.733,430,765,956.95
流动负债:
短期借款64,300,777.7860,002,611.0860,002,611.0860,002,611.08
应付票据及应付账款35,805,001.4153,792,037.9156,071,915.6655,827,922.71
应付账款35,805,001.4153,792,037.9156,071,915.6655,827,922.71
合同负债60,079,350.0973,239,572.999,695,612.9396,146,185.73
应付职工薪酬61,923,197.0357,616,415.6650,310,132.7741,783,737.85
应交税费3,949,087.758,461,058.166,511,456.994,827,398.31
其他应付款合计84,774,044.8898,709,481.71159,169,147.6150,510,926.42
一年内到期的非流动负债73,669,116.4173,932,423.4570,189,707.0378,838,535.09
其他流动负债431,047.511,021,144.891,359,566.651,959,788.4
流动负债平衡项目0000
流动负债合计384,931,622.86426,774,745.76503,310,150.71489,897,105.59
非流动负债:
长期借款43,674,91643,674,91647,083,90041,015,000
租赁负债438,450,700.72457,730,352.76474,000,601.47491,868,854.66
预计负债5,298,933.375,242,824.85,187,310.345,132,383.71
递延收益26,486,65527,433,414.0617,038,957.0215,844,550.94
递延所得税负债10,309,538.3712,581,068.749,889,629.4713,106,200.03
非流动负债平衡项目0000
非流动负债合计524,220,743.46546,662,576.36553,200,398.3566,966,989.34
负债平衡项目0000
负债合计909,152,366.32973,437,322.121,056,510,549.011,056,864,094.93
所有者权益(或股东权益):
实收资本(或股本)499,776,892499,776,892499,776,892499,776,892
资本公积1,229,187,219.211,229,187,219.211,229,187,219.211,229,187,219.21
减:库存股25,506,290.2425,506,290.2425,506,290.2425,506,290.24
其他综合收益19,512,064.5717,636,124.8719,814,715.7919,598,677.41
盈余公积169,649,539.17169,649,539.17169,649,539.17169,649,539.17
未分配利润-454,787,435.81-429,326,885.15437,412,016.91456,839,877.25
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计1,437,831,988.91,461,416,599.862,330,334,092.842,349,545,914.8
少数股东权益24,199,807.9224,239,008.1424,279,621.8824,355,947.22
股东权益平衡项目0000
股东权益合计1,462,031,796.821,485,655,6082,354,613,714.722,373,901,862.02
负债和股东权益合计2,371,184,163.142,459,092,930.123,411,124,263.733,430,765,956.95
公告日期2024-04-262024-04-262023-10-252023-08-29
审计意见(境内)标准无保留意见
TOP↑